[Malignant peritoneal mesothelioma. Our experienced with triple combined therapy: cytoreduction, intraperitoneal perioperative chemotherapy and hyperthermia]
/in Hyperthermia, International Publications, Malignant Pleural MesotheliomaEnhanced T-cell immunity induced by dendritic cells with phagocytosis of heat shock protein 70 gene-transfected tumor cells in early phase of apoptosis
/in Dendritic Cells, Hyperthermia, International PublicationsAntigenic profiling of glioma cells to generate allogeneic vaccines or dendritic cell-based therapeutics
/in Glioblastoma, International PublicationsSystemic efficacy with oncolytic virus therapeutics: clinical proof-of-concept and future directions
/in International Publications, Newcastle Disease Virusp53-independent endoplasmic reticulum stress-mediated cytotoxicity of a Newcastle disease virus strain in tumor cell lines
/in Glioblastoma, International Publications, Newcastle Disease VirusInduction of dendritic cell-mediated immune responses against canine malignant melanoma cells
/in International Publications, Malignant MelanomaGeneration and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells
/in Breast Cancer, International PublicationsResults of a pilot trial of immunotherapy with dendritic cells pulsed with autologous tumor lysates in patients with advanced cancer
/in Breast Cancer, International Publications, Malignant Melanoma[Immunotherapy and malignant mesothelioma: clinical perspectives]
/in International Publications, Malignant Pleural Mesothelioma
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Die IOZK Immuntherapie
Aktuelles und Int. Publikationen
- WT1-mRNA dendritic cell vaccination of patients with glioblastoma multiforme, malignant pleural mesothelioma, metastatic breast cancer, and other solid tumors: type 1 T-lymphocyte responses are associated with clinical outcome
- Autologous tumor lysate-loaded dendritic cell vaccination in glioblastoma patients: a systematic review of literature
- Retrospective Analysis of HLA Class II-Restricted Neoantigen Peptide-Pulsed Dendritic Cell Vaccine for Breast Cancer